{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-127477","form_type":"8-K","ticker":"HIND","cik":"0001427570","company_name":"Vyome Holdings, Inc","filed_at":"2024-12-11T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.426981+00:00","generated_at":"2026-05-29T04:40:33.055483+00:00","sec_items":["7.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"medium","headline":"ReShape Lifesciences announces pending merger with Vyome Therapeutics; ticker to change to $HIND","bullets":["Merger with Vyome Therapeutics Inc. and asset sale to Biorad Medisys or affiliate.","Ticker symbol to change from RSLS to HIND upon closing.","Investor presentation furnished as Exhibit 99.1, highlighting clinical-stage immunoinflammation assets.","No specific deal value or premium disclosed in this filing.","Approval required from ReShape stockholders; joint proxy statement/prospectus to be filed."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-127477","json":"https://secwatch.observer/filing/0001104659-24-127477.json","markdown":"https://secwatch.observer/filing/0001104659-24-127477.md","text":"https://secwatch.observer/filing/0001104659-24-127477.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1427570/000110465924127477/0001104659-24-127477-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1427570/000110465924127477/tm2430703d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T04:40:33.055483+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}